Skip nav
Stroke

Oxford, UK: Brainomix Limited, a developer of automated medical imaging software for neurological and cerebrovascular disorders, has been awarded £633,553 by the Biomedical Catalyst, a joint programme run by the Medical Research Council (MRC) and Innovate UK. The funding is for two years and will support the development and validation of clinical decision-making support software designed to identify stroke patients who can benefit from mechanical reopening of a brain artery.

“We are very honoured to receive this award. We are now able to develop software that will empower physicians to identify stroke patients who benefit from the life-saving, but expensive treatment of mechanical clot removal,” said Dr Michalis Papadakis, Brainomix Chief Executive Officer.
Read full release

Image Channel